289 related articles for article (PubMed ID: 30245513)
1. KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.
Kennedy J; Goudie D; Blair E; Chandler K; Joss S; McKay V; Green A; Armstrong R; Lees M; Kamien B; Hopper B; Tan TY; Yap P; Stark Z; Okamoto N; Miyake N; Matsumoto N; Macnamara E; Murphy JL; McCormick E; Hakonarson H; Falk MJ; Li D; Blackburn P; Klee E; Babovic-Vuksanovic D; Schelley S; Hudgins L; Kant S; Isidor B; Cogne B; Bradbury K; Williams M; Patel C; Heussler H; Duff-Farrier C; Lakeman P; Scurr I; Kini U; Elting M; Reijnders M; Schuurs-Hoeijmakers J; Wafik M; Blomhoff A; Ruivenkamp CAL; Nibbeling E; Dingemans AJM; Douine ED; Nelson SF; ; Hempel M; Bierhals T; Lessel D; Johannsen J; Arboleda VA; Newbury-Ecob R
Genet Med; 2019 Apr; 21(4):850-860. PubMed ID: 30245513
[TBL] [Abstract][Full Text] [Related]
2. A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay.
Trinh J; Hüning I; Yüksel Z; Baalmann N; Imhoff S; Klein C; Rolfs A; Gillessen-Kaesbach G; Lohmann K
J Hum Genet; 2018 Sep; 63(9):997-1001. PubMed ID: 29899504
[TBL] [Abstract][Full Text] [Related]
3. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
Tham E; Lindstrand A; Santani A; Malmgren H; Nesbitt A; Dubbs HA; Zackai EH; Parker MJ; Millan F; Rosenbaum K; Wilson GN; Nordgren A
Am J Hum Genet; 2015 Mar; 96(3):507-13. PubMed ID: 25728777
[TBL] [Abstract][Full Text] [Related]
4. Speech and language development and genotype-phenotype correlation in 49 individuals with KAT6A syndrome.
St John M; Amor DJ; Morgan AT
Am J Med Genet A; 2022 Dec; 188(12):3389-3400. PubMed ID: 35892268
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Arboleda-Tham syndrome by whole-exome sequencing in an Asian girl with severe developmental delay.
Wang Q; Zhang Y; Li L; Yang N
Mol Genet Genomic Med; 2024 May; 12(5):e2420. PubMed ID: 38773911
[TBL] [Abstract][Full Text] [Related]
6. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.
Arboleda VA; Lee H; Dorrani N; Zadeh N; Willis M; Macmurdo CF; Manning MA; Kwan A; Hudgins L; Barthelemy F; Miceli MC; Quintero-Rivera F; Kantarci S; Strom SP; Deignan JL; ; Grody WW; Vilain E; Nelson SF
Am J Hum Genet; 2015 Mar; 96(3):498-506. PubMed ID: 25728775
[TBL] [Abstract][Full Text] [Related]
7. Fetal hepatic calcification in severe KAT6A (Arboleda-Tham) syndrome.
Di Caprio A; Rossi C; Bertucci E; Bedetti L; Bertoncelli N; Miselli F; Corso L; Bondi C; Iughetti L; Berardi A; Lugli L
Eur J Med Genet; 2024 Feb; 67():104906. PubMed ID: 38143025
[TBL] [Abstract][Full Text] [Related]
8. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
[TBL] [Abstract][Full Text] [Related]
9. De novo and biallelic DEAF1 variants cause a phenotypic spectrum.
Nabais Sá MJ; Jensik PJ; McGee SR; Parker MJ; Lahiri N; McNeil EP; Kroes HY; Hagerman RJ; Harrison RE; Montgomery T; Splitt M; Palmer EE; Sachdev RK; Mefford HC; Scott AA; Martinez-Agosto JA; Lorenz R; Orenstein N; Berg JN; Amiel J; Heron D; Keren B; Cobben JM; Menke LA; Marco EJ; Graham JM; Pierson TM; Karimiani EG; Maroofian R; Manzini MC; Cauley ES; Colombo R; Odent S; Dubourg C; Phornphutkul C; de Brouwer APM; de Vries BBA; Vulto-vanSilfhout AT
Genet Med; 2019 Sep; 21(9):2059-2069. PubMed ID: 30923367
[TBL] [Abstract][Full Text] [Related]
10. Genotype and phenotype in 12 additional individuals with SATB2-associated syndrome.
Zarate YA; Kalsner L; Basinger A; Jones JR; Li C; Szybowska M; Xu ZL; Vergano S; Caffrey AR; Gonzalez CV; Dubbs H; Zackai E; Millan F; Telegrafi A; Baskin B; Person R; Fish JL; Everman DB
Clin Genet; 2017 Oct; 92(4):423-429. PubMed ID: 28139846
[TBL] [Abstract][Full Text] [Related]
11. Toward clinical and molecular understanding of pathogenic variants in the ZBTB18 gene.
van der Schoot V; de Munnik S; Venselaar H; Elting M; Mancini GMS; Ravenswaaij-Arts CMA; Anderlid BM; Brunner HG; Stevens SJC
Mol Genet Genomic Med; 2018 May; 6(3):393-400. PubMed ID: 29573576
[TBL] [Abstract][Full Text] [Related]
12. De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.
van den Akker WMR; Brummelman I; Martis LM; Timmermans RN; Pfundt R; Kleefstra T; Willemsen MH; Gerkes EH; Herkert JC; van Essen AJ; Rump P; Vansenne F; Terhal PA; van Haelst MM; Cristian I; Turner CE; Cho MT; Begtrup A; Willaert R; Fassi E; van Gassen KLI; Stegmann APA; de Vries BBA; Schuurs-Hoeijmakers JHM
Clin Genet; 2018 May; 93(5):1000-1007. PubMed ID: 29393965
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy in KAT6A syndrome: Description of two individuals and revision of the literature.
Troisi S; Maitz S; Severino M; Spano A; Cappuccio G; Brunetti-Pierri N; Torella A; Nigro V; Tudp ; Bilo L; Coppola A
Eur J Med Genet; 2022 Jan; 65(1):104380. PubMed ID: 34748993
[TBL] [Abstract][Full Text] [Related]
14. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
15. Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum.
Urreizti R; Lopez-Martin E; Martinez-Monseny A; Pujadas M; Castilla-Vallmanya L; Pérez-Jurado LA; Serrano M; Natera-de Benito D; Martínez-Delgado B; Posada-de-la-Paz M; Alonso J; Marin-Reina P; O'Callaghan M; Grinberg D; Bermejo-Sánchez E; Balcells S
Orphanet J Rare Dis; 2020 Feb; 15(1):44. PubMed ID: 32041641
[TBL] [Abstract][Full Text] [Related]
16. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing.
Hiraide T; Yamoto K; Masunaga Y; Asahina M; Endoh Y; Ohkubo Y; Matsubayashi T; Tsurui S; Yamada H; Yanagi K; Nakashima M; Hirano K; Sugimura H; Fukuda T; Ogata T; Saitsu H
Clin Genet; 2021 Jul; 100(1):40-50. PubMed ID: 33644862
[TBL] [Abstract][Full Text] [Related]
17. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
[TBL] [Abstract][Full Text] [Related]
18. Clinical characterization of individuals with the distal 1q21.1 microdeletion.
Edwards SD; Schulze KV; Rosenfeld JA; Westerfield LE; Gerard A; Yuan B; Grigorenko EL; Posey JE; Bi W; Liu P
Am J Med Genet A; 2021 May; 185(5):1388-1398. PubMed ID: 33576134
[TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
Kaymakcalan H; Yarman Y; Goc N; Toy F; Meral C; Ercan-Sencicek AG; Gunel M
Am J Med Genet A; 2018 Feb; 176(2):421-425. PubMed ID: 29226631
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies.
Glinton KE; Hurst ACE; Bowling KM; Cristian I; Haynes D; Adstamongkonkul D; Schnappauf O; Beck DB; Brewer C; Parikh AS; Shinde DN; Donaldson A; Brautbar A; Koene S; van Haeringen A; Piton A; Capri Y; Furlan M; Gardella E; Møller RS; van de Beek I; Zuurbier L; Lakeman P; Bayat A; Martinez J; Signer R; Torring PM; Engelund MB; Gripp KW; Amlie-Wolf L; Henderson LB; Midro AT; Tarasów E; Stasiewicz-Jarocka B; Moskal-Jasinska D; Vos P; Boschann F; Stoltenburg C; Puk O; Mero IL; Lossius K; Mignot C; Keren B; Acosta Guio JC; Briceño I; Gomez A; Yang Y; Stankiewicz P
Am J Med Genet A; 2021 May; 185(5):1366-1378. PubMed ID: 33522091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
